Minireviews
Copyright ©The Author(s) 2025.
World J Hepatol. Aug 27, 2025; 17(8): 108678
Published online Aug 27, 2025. doi: 10.4254/wjh.v17.i8.108678
Table 2 A summary table for key studies and their conclusions
Ref.
Year
Study design
Findings
Limitations
Wang et al[74]2024Cross-sectional studyHCV group without metabolic syndrome had higher odds ratio of 2.75While CT is a widely used method, it primarily detects advanced atherosclerosis (calcified plaques) and may miss earlier stages of the disease
Chang et al[56]2022Population-based cohortHCV patients have a high incidence of CVD, though it is lower than that of ALD and NAFLDThe findings may not be directly generalizable
Petta et al[9]2011Case-controlSevere hepatic fibrosis is associated with a high risk of early carotid atherosclerosis in G1 CHC patientsSelection bias in the recruitment of the control population and limited generalizability
Lee et al[72]2019Systematic review and meta-analysisPatients with HCV had 28% higher risk compared to those without HCV infectionLimited generalizability on global scale, and significant heterogeneity
Wen et al[75]2019Systematic review and meta-analysisThe overall RR of 1.25 in the cohort studies, higher OR of 1.94 in these studies suggests a stronger association between HCV and CAD compared to the cohort studiesSmall sample size between studies and different criteria for diagnosing CHC
Badawi et al[76]2018Survey analysisHCV infection was significantly associated with a 25%-3.5% absolute risk increases of 10-year CVD after adjusting for sociodemographic and cardiometabolic risk factorsConfounding variables such as alcohol use, and drug use were not controlled
Roed et al[65]2014Cross-sectional studyHigher carotid intima media thickness in CHC patients with small difference of meansConfounding variables such as physical activity, diet, medication use, family history of CAD, and genetic predisposition were not controlled